Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2022

Jul 20, 2022

62616_rns_2022-07-20_9ca1ecab-115e-4146-9d59-fcda08fb561f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

July 20, 2022

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.

Scrip Code: 532531

Dear Sirs,

Sub: Intimation of raising of funds by way of issuance of Non-Convertible Debentures

We would like to inform you that a meeting of the Committee of Directors is scheduled to be held on Monday, July 25, 2022, inter alia, to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCD) on a private placement basis.

This intimation is being issued pursuant to Regulation 29 of SEBI Listing Regulations, 2015.

We request you to kindly take the same on your records.

Thanks & Regards,

For Strides Pharma Science Limited,

Manjula R Company Secretary

==> picture [84 x 83] intentionally omitted <==

==> picture [479 x 52] intentionally omitted <==